Call Now

Mouse IL17RA / IL17R / CD217 Protein (His Tag)

AW538159,Cdw217,Il17r,VDw217

Catalog Number P50328-M08H
Organism Species Mouse
Host Human Cells
Synonyms AW538159,Cdw217,Il17r,VDw217
Molecular Weight The secreted recombinant mouse IL17RA consists of 302 amino acids and has a predicted molecular mass of 34.8 kDa. As a result of glycosylation, the apparent molecular mass of rmIL17RA is approximately 55-60 kDa in SDS-PAGE under reducing conditions.
predicted N Ser 32
SDS-PAGE
Purity > 98 % as determined by SDS-PAGE
Protein Construction A DNA sequence encoding the mouse IL17RA (NP_032385.1) extracellular domain (Met 1-Trp 322) was fused with a polyhistidine tag at the C-terminus.
Bio-activity 1. Measured by its binding ability in a functional ELISA.
2. Immobilized recombinant human IL17A at 2 μg/ml (100 μl/well) can bind biotinylated mouse IL17RA with a linear range of 1.28-6.4 ng/ml.
Research Area Immunology |Adaptive Immunity |T Cell |T Cell CD Antigen |CD Antigen (Helper T Cells)
Formulation Lyophilized from sterile PBS, pH 7.4
1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
Background Interleukin-17 receptor (IL-17R), also known as Interleukin-17 receptor A (IL-17RA) and CD217 antigen (CD217), is a cytokine receptor which binds interleukin 17. IL-17R/IL-17RA (CD217) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. IL-17R/IL-17RA (CD217) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor IL-17RA play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Defects in IL-17R/IL-17RA (CD217) are the cause of familial candidiasis type 5 (CANDF5). CANDF5 is a rare disorder with altered immune responses and impaired clearance of fungal infections, selective against Candida. It is characterized by persistent and/or recurrent infections of the skin, nails and mucous membranes caused by organisms of the genus Candida, mainly Candida albicans.
Reference
  • Gaffen SL. (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 9 (8): 556-67.
  • Johansen C, et al.. (2009) Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 160 (2): 319-24.
  • Yao Z, et al.. (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9 (11): 794-800.